₹229.30
+6.10 (+2.73%)
As of 18 Sept 2026, Samrat Pharmachem Ltd share price is ₹229.30. The stock opened at ₹229.30 and had closed at ₹223.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹190.00 and a high of ₹333.00. In terms of performance, Samrat Pharmachem Ltd share price has increased by 3.50% over the past six months and has decreased by 30.80% over the last year.
Samrat Pharma Stock Price Chart
Samrat Pharmachem Ltd Overview
Market cap₹71 Crs
Volume342
Prev. Close₹223.20
Year range₹190.00 - ₹333.00
ISININE103E01016
About Samrat Pharma
Samrat Pharmachem is engaged in the business of business of pharmaceutical chemicals. The company gets its income from selling of pharmaceutical chemicals in domestic and international market.
Samrat Pharmachem Ltd Historical Performance
1 Month Return-2.66%
6 Month Return8.35%
3 Year Return-44.18%
3 Month Return10.71%
1 Year Return-30.77%
5 Year Return1.80%
Samrat Pharmachem Ltd Fundamentals
ROCE(TTM)-2.57%
P/E Ratio (TTM)-31.26
P/B Ratio1.01
Debt to Equity0.16
ROE-4.86%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value220.67
Profit Margin-0.75%
Operating Margin-0.71%
Samrat Pharmachem Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 290.55 | 286.83 | 282.96 | 311.13 | 222.38 |
| EBITDA | -1.30 | 11.21 | 3.86 | 24.40 | 24.86 |
| Net Profit | -3.31 | 7.11 | 2.16 | 16.63 | 17.18 |
| EPS | -10.72 | 23.02 | 7.00 | 53.83 | 55.62 |
Samrat Pharmachem Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 215.53 |
| Resistance 1 (R1) | 227.18 |
| Pivot Point | 219.52 |
Samrat Pharmachem Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Sep-2025 | 30-May-2025 | 18-Sep-2025 | Final | ₹1.00 |
| 19-Sep-2024 | 30-May-2024 | 19-Sep-2024 | Final | ₹1.00 |
| 18-Sep-2023 | 30-May-2023 | 18-Sep-2023 | Final | ₹1.00 |
| 22-Sep-2022 | 30-May-2022 | 23-Sep-2022 | Final | ₹1.00 |
Samrat Pharmachem Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Lalit Mehta | Chairman & Managing Director |
| Rajesh Mehta | Chief Financial Officer |
| Megh Mehta | Whole Time Executive Directorector |
Samrat Pharmachem Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Samrat Pharmachem Ltd today is ₹229.30 on NSE and ₹229.30 on BSE.
- The 52-week high of Samrat Pharmachem Ltd is ₹333.00, while the 52-week low is ₹190.00.
- The current market capitalisation of Samrat Pharmachem Ltd is approximately ₹71 crore.
- The P/E (Price-to-Earnings) ratio of Samrat Pharmachem Ltd is -31.26. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Samrat Pharmachem Ltd is 1.01. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Samrat Pharmachem Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Samrat Pharma on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Samrat Pharmachem Ltd has delivered a return of approximately -44.18%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Samrat Pharmachem Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.09% promoters, 3.24% FIIs, 0.00% DIIs, and 41.51% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
